Evidence map›Paper›PMID 8391253›Full record

ReviewThe Biochemical journal1993

Platelet-activating factor: receptors and signal transduction.

W Chao, M S Olson

Open access · greenAbstract readReview
In one paragraph

Review in The Biochemical journal, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
27.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 459 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

W ChaoDepartment of Biochemistry, University of Texas Health Science Center, San Antonio 78284-7760.
M S Olson
The University of Texas Health Science Center at San Antonio · US

Funding

REGULATORY MECHANISMS IN KETOGENESIS AND GLUCONEOGENESISR01DK019473 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI OLSON, MERLE S · 1986 to 1999
–
AGEPC--A POTENT LIPID BIOCHEMICAL MEDIATOR IN LIVERR01DK033538 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI OLSON, MERLE S · 1986 to 1998
–
NIDDK NIH HHS DK-19473NIDDK NIH HHS DK-33538
6 · The paper itself

Abstract

During the past two decades, studies describing the chemistry and biology of PAF have been extensive. This potent phosphoacylglycerol exhibits a wide variety of physiological and pathophysiological effects in various cells and tissues. PAF acts, through specific receptors and a variety of signal transduction systems, to elicit diverse biochemical responses. Several important future directions can be enumerated for the characterization of PAF receptors and their attendant signalling mechanisms. The recent cloning and sequence analysis of the gene for the PAF receptor will allow a number of important experimental approaches for characterizing the structure and analysing the function of the various domains of the receptor. Using molecular genetic and immunological technologies, questions relating to whether there is receptor heterogeneity, the precise mechanism(s) for the regulation of the PAF receptor, and the molecular details of the signalling mechanisms in which the PAF receptor is involved can be explored. Another area of major significance is the examination of the relationship between the signalling response(s) evoked by PAF binding to its receptor and signalling mechanisms activated by a myriad of other mediators, cytokines and growth factors. A very exciting recent development in which PAF receptors undoubtedly play a role is in the regulation of the function of various cellular adhesion molecules. Finally, there remain many incompletely characterized physiological and pathophysiological situations in which PAF and its receptor play a crucial signalling role. Our laboratory has been active in the elucidation of several tissue responses in which PAF exhibits major autocoid signalling responses, e.g. hepatic injury and inflammation, acute and chronic pancreatitis, and cerebral stimulation and/or trauma. As new experimental strategies are developed for characterizing the fine structure of the molecular mechanisms involved in tissue injury and inflammation, the essential role of PAF as a primary signalling molecule will be affirmed. Doubtless the next 20 years of experimental activity will be even more interesting and productive than the past two decades.

Indexed as

Platelet Membrane GlycoproteinsReceptors, G-Protein-CoupledSignal TransductionAnimalsArachidonic AcidCalciumCell MembraneGTP-Binding ProteinsHumansLiverModels, BiologicalPhosphatidylinositolsPlatelet Activating FactorProtein Structure, SecondaryProtein-Tyrosine KinasesReceptors, Cell SurfaceArachidonic AcidCalciumGTP-Binding ProteinsPhosphatidylinositolsPlatelet Activating Factorplatelet activating factor receptorPlatelet Membrane GlycoproteinsProtein-Tyrosine KinasesReceptors, Cell SurfaceReceptors, G-Protein-Coupled

Identifiers

PMID8391253
PMCPMC1134157
OpenAlexW2153912688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.